Rhenman & Partners Asset Management AB

13F Portfolio Filings

Most recent 13F
Q2 2026
Location
Stockholm, Sweden
CIK
0001599882
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 99 1,059,428 UNH, CVS, AZN, MRK 13F-HR 8/13/2026 000121390026088652
Q1 2026 86 810,490 BSX, REGN, LLY, INSM 13F-HR 5/14/2026 000121390026056196
Q4 2025 94 1,069,994 REGN, LLY, BSX, MDT 13F-HR 2/13/2026 000121390026015821
Q3 2025 92 903,669 BSX, LLY, ABBV, DHR 13F-HR 11/13/2025 000121390025109534
Q2 2025 90 791,015 LLY, BSX, VRTX, GKOS 13F-HR 8/13/2025 000121390025075249
Q1 2025 94 869,998 UNH, LLY, VRTX, MCK 13F-HR 5/14/2025 000121390025042939
Q4 2024 92 972,946 BSX, LLY, PRCT, ISRG 13F-HR 2/13/2025 000121390025013150
Q3 2024 95 1,232,086 BSX, UNH, LLY, REGN 13F-HR 11/13/2024 000121390024097092
Q2 2024 93 1,041,575 UNH, ELV, BSX, LLY 13F-HR 8/13/2024 000121390024067896
Q1 2024 84 1,055,081 CI, LLY, THC, BSX 13F-HR 5/14/2024 000121390024042547
Q4 2023 85 1,001,011 MDT, LLY, BSX, VRTX 13F-HR 2/13/2024 000121390024012894
Q3 2023 85 927,505 LLY, BSX, BMRN, REGN RESTATEMENT 11/13/2023 000121390023085459
Q2 2023 83 948,682 LLY, BMRN, CI, BSX 13F-HR 8/11/2023 000121390023065840
Q1 2023 88 910,885 LILLY ELI & CO, UNH, BSX, REGN 13F-HR 5/11/2023 000121390023038637
Q4 2022 93 958,473 LLY, COR, MDT, BSX 13F-HR 2/13/2023 000121390023010457
Q3 2022 90 955,010 LLY, UNH, BSX, VRTX 13F-HR 11/14/2022 000121390022072302
Q2 2022 86 880,150 CI, LLY, ABBV, UNH 13F-HR 8/12/2022 000121390022047070
Q1 2022 89 1,013,563 LLY, HZNP, ABBV, UNH 13F-HR 5/13/2022 000121390022026487
Q4 2021 92 1,503,868 UNH, PFE, LLY, HZNP 13F-HR 2/11/2022 000121390022006636
Q3 2021 92 1,424,766 HZNP, UNH, ELV, JNJ 13F-HR 11/12/2021 000121390021058306
Q2 2021 94 1,473,245 UNH, HZNP, VRTX, JAZZ 13F-HR 8/13/2021 000121390021042239
Q1 2021 92 1,434,218 HZNP, JNJ, UNH, JAZZ 13F-HR 5/14/2021 000121390021026215
Q4 2020 83 1,225,693 ABBV, BMRN, HZNP, MDT 13F-HR 1/19/2021 000121390021002698
Q3 2020 82 1,124,651 BMRN, HZNP, NVCR, UNH 13F-HR 10/13/2020 000121390020031038
Q2 2020 94 925,638 HZNP, VRTX, UNH, ABBV 13F-HR 7/16/2020 000121390020017623
Q1 2020 85 713,821 HZNP, VRTX, ABBV, NVCR 13F-HR 4/16/2020 000121390020009314
Q4 2019 94 912,515 ESPR, VRTX, NVCR, HZNP 13F-HR 1/17/2020 000121390020001297
Q3 2019 93 797,699 VRTX, HZNP, NVCR, ALXN 13F-HR 10/16/2019 000121390019020405
Q2 2019 88 907,850 VRTX, HUM, JAZZ, ALXN 13F-HR 7/22/2019 000121390019013307
Q1 2019 93 854,928 UNH, JAZZ, VRTX, ABMD 13F-HR 4/11/2019 000121390019006146
Q4 2018 89 874,811 UNH, CI, MDT, CVS 13F-HR 2/5/2019 000121390019001686
Q3 2018 88 997,986 CI, CVS, ALXN, VRTX 13F-HR 10/3/2018 000141588918001462
Q2 2018 89 977,105 NKTR, HZNP, VRTX, INCY 13F-HR 7/20/2018 000141588918001149
Q1 2018 92 811,255 HZNP, CELG, ALXN, VRTX 13F-HR 4/11/2018 000141588918000595
Q4 2017 95 740,066 HZNP, ESPR, ADMS, EXEL 13F-HR 1/19/2018 000141588918000085
Q3 2017 94 783,338 HZNP, VRTX, EXEL, ABMD 13F-HR 10/13/2017 000141588917001660
Q2 2017 108 696,477 HZNP, EXEL, NVCR, ALXN 13F-HR 7/11/2017 000141588917001145
Q1 2017 104 631,470 HZNP, ESPR, BIIB, GKOS 13F-HR 4/19/2017 000141588917000651
Q4 2016 108 521,630 GILD, BMY, AGN, LLY 13F-HR 1/13/2017 000141588917000078
Q3 2016 107 629,612 SHPG, LLY, ALXN, CELG 13F-HR 11/8/2016 000141588916007347
Q2 2016 97 563,148 ALXN, GILD, CELG, BIIB 13F-HR 8/1/2016 000141588916006640
Q1 2016 92 503,761 ALXN, GILD, BMRN, PFE 13F-HR 4/19/2016 000141588916005562
Q4 2015 96 661,398 PRGO, ABMD, MDT, ALXN 13F-HR 1/19/2016 000141588916004481
Q3 2015 91 627,273 AMGN, ALXN, MDT, UNH 13F-HR 10/26/2015 000141588915003497
Q2 2015 96 706,819 iShares Tr Nasdaq Biotech ETF puts, Select Sector SPDR Tr SBI Healthcare puts, UNH, ALXN 13F-HR 7/30/2015 000141588915002492
Q1 2015 89 561,172 SELECT SECTOR SPDR TR puts, ALXN, CELG, MRK 13F-HR 5/13/2015 000141588915001643
Q4 2014 84 345,008 CELG, GILD, CVS, REGN 13F-HR 2/9/2015 000141588915000450
Q3 2014 100 326,609 Johnson & Johnson calls, ALKS, UHS, ALXN 13F-HR 11/3/2014 000141588914003285
Q2 2014 96 337,007 BIIB, COV, GILD, ALXN 13F-HR 7/31/2014 000141588914002277
Q1 2014 91 328,256 GILD, ALXN, REGN, BIIB 13F-HR 5/14/2014 000152153614000049
Q4 2013 84 251,079 REGN, CELG, GILD, CVS 13F-HR 2/14/2014 000152153614000045
Additional filings from Rhenman & Partners Asset Management AB that have since been restated